Agilon Health (NYSE:AGL) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.26) by 78.99 percent. This is a 76.92 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $1.569 billion which beat the analyst consensus estimate of $1.461 billion by 7.37 percent. This is a 3.09 percent increase over sales of $1.522 billion the same period last year.